← Patent-cliff monitor small molecule VALTOCO DIAZEPAM
Loss of exclusivity June 2042 latest FDA-listed patent expiry
Drug detail Brand name VALTOCO Active ingredient DIAZEPAM Strength 5MG/SPRAY Dosage form SPRAY Route NASAL Modality Small molecule FDA approval January 2020 Marketing status RX
Listed patents Patent Expires Type 12599611 June 2042 use U-4455 12324852 October 2032 use U-4173 12337061 June 2032 use U-4173 12268664 March 2029 product 8895546 March 2029 product 11241414 March 2029 product 12521400 March 2029 product 11793786 March 2029 product
Regulatory exclusivity Code Expires NPP April 2028 ODE-279 January 2027
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.